Drug Information

Drug General Information
Drug ID
D07SMH
Former ID
DCL001216
Drug Name
MK-5172
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 2 [551141]
Company
Merck
Structure
Download
2D MOL

3D MOL
Formula
C29H38N4O7
Canonical SMILES
CC(C)(C)C1C(=O)N2CC(CC2C(=O)O)OC3=NC4=C(C=CC(=C4)OC)N=C<br />3CCCCCC5CC5OC(=O)N1
InChI
1S/C29H38N4O7/c1-29(2,3)24-26(34)33-15-18(14-22(33)27(35)36)39-25-20(30-19-11-10-17(38-4)13-21(19)31-25)9-7-5-6-8-16-12-23(16)40-28(37)32-24/h10-11,13,16,18,22-24H,5-9,12,14-15H2,1-4H3,(H,32,37)(H,35,36)/t16-,18-,22+,23-,24-/m1/s1
InChIKey
IVROMYPOGKZNLP-FDOFPDFBSA-N
PubChem Compound ID
46930991
PubChem Substance ID
99437277, 162108841, 164188467, 165245626, 198946987, 210278991, 224354588, 228307499
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [551141]
References
Ref 551141Clinical pipeline report, company report or official report of Merck (2011).
Ref 551141Clinical pipeline report, company report or official report of Merck (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.